LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU=Grundy Scott M
  2. AU="Koumoutsea, Evangelia Vlachodimitropoulou"
  3. AU="Almen, Aimee"
  4. AU="Howard, Dianna S."
  5. AU="Elizete Rizzo"
  6. AU="El Sayegh, Suzanne"
  7. AU="Vaittinen, Tiina"
  8. AU="Khir, Amir S"
  9. AU=Patterson Andrew D
  10. AU="Kim, Joyce Mary"
  11. AU="Saribay, S Adil"
  12. AU="Couderc, M."
  13. AU="Macerlane de Lira Silva"
  14. AU=Neal Michael S
  15. AU="Nakai, Kozo"
  16. AU="Debatin, Jörg F."
  17. AU="Plant, Laura"
  18. AU="Manuel Tisminetzky"
  19. AU="Monaco, Carlo"
  20. AU="Srivastava, Rupesh"
  21. AU="Nathan, Jaimie D"
  22. AU="Schnegelberger, Regina D"
  23. AU=Doshi Paresh
  24. AU="Cecilia Hognon"
  25. AU="Mason, Jeremy K."
  26. AU=Hasumi Hisashi
  27. AU="Swati Sethi"
  28. AU="Martin G. Myers, Jr."
  29. AU="Marcus-Sekura, Carol"
  30. AU="Petagine, Lucy"
  31. AU="Jessa R. Alexander"
  32. AU=Rauner Martina
  33. AU="Richlen, Mindy L"
  34. AU="Merghani, Nada M"
  35. AU=Splitt M P
  36. AU="Zlatanović, Gordana"

Suchergebnis

Treffer 1 - 10 von insgesamt 373

Suchoptionen

  1. Artikel: Toward optimal health: Scott Grundy, M.D., Ph.D. discusses metabolic syndrome ( interviewed by Jodi R. Godfrey).

    Grundy, Scott

    Journal of women's health (2002)

    2005  Band 14, Heft 10, Seite(n) 883–888

    Mesh-Begriff(e) Health Knowledge, Attitudes, Practice ; Health Status ; Humans ; Metabolic Syndrome/diagnosis ; Metabolic Syndrome/prevention & control ; Metabolic Syndrome/therapy ; Quality of Life ; Risk Factors ; United States ; Women's Health
    Sprache Englisch
    Erscheinungsdatum 2005-12
    Erscheinungsland United States
    Dokumenttyp Interview
    ZDB-ID 1139774-3
    ISSN 1931-843X ; 1540-9996 ; 1059-7115
    ISSN (online) 1931-843X
    ISSN 1540-9996 ; 1059-7115
    DOI 10.1089/jwh.2005.14.883
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Buch: Atlas of atherosclerosis and metabolic syndrome

    Grundy, Scott M.

    2011  

    Verfasserangabe ed. Scott M. Grundy
    Sprache Englisch
    Umfang IX, 304 S. : Ill., graph. Darst.
    Ausgabenhinweis 5. ed.
    Verlag Springer
    Erscheinungsort New York u.a.
    Erscheinungsland Vereinigte Staaten
    Dokumenttyp Buch
    HBZ-ID HT016688330
    ISBN 978-1-4419-5838-9 ; 9781441958396 ; 1-4419-5838-X ; 1441958398
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Zusatzmaterialien

    Kategorien

  3. Buch ; Konferenzbeitrag: Managing cardiometabolic risk: will new approaches improve success?

    Grundy, Scott M.

    based on a symposium held on June 11, 2006 in Washington, DC

    (The American journal of medicine ; 120,9A = Suppl. ; CME issue)

    2007  

    Verfasserangabe guest ed.: Scott M. Grundy
    Serientitel The American journal of medicine ; 120,9A = Suppl.
    CME issue
    Überordnung
    Sprache Englisch
    Umfang S38 S. : Ill., graph. Darst.
    Verlag Elsevier
    Erscheinungsort New York, NY u.a.
    Erscheinungsland Vereinigte Staaten
    Dokumenttyp Buch ; Konferenzbeitrag
    HBZ-ID HT015295369
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Zusatzmaterialien

    Kategorien

  4. Buch: Dyslipidemia in metabolic syndrome

    Grundy, Scott M.

    (Clinical cornerstone ; 8, Suppl. 1)

    2006  

    Verfasserangabe guest ed. Scott M. Grundy
    Serientitel Clinical cornerstone ; 8, Suppl. 1
    Überordnung
    Sprache Englisch
    Umfang S35 S.
    Verlag Excerpta Medica
    Erscheinungsort Bridgewater, NJ
    Erscheinungsland Vereinigte Staaten
    Dokumenttyp Buch
    HBZ-ID HT014797813
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Zusatzmaterialien

    Kategorien

  5. Buch: Atlas of atherosclerosis

    Grundy, Scott M.

    risk factors & treatment

    2005  

    Verfasserangabe ed. Scott M. Grundy
    Schlagwörter Arteriosclerosis / pathology ; Arteriosclerosis / therapy ; Lipoproteins / metabolism ; Risk Factors
    Sprache Englisch
    Umfang VIII, 296 S. : Ill., graph. Darst.
    Ausgabenhinweis 4. ed.
    Verlag Current Medicine
    Erscheinungsort Philadelphia
    Erscheinungsland Vereinigte Staaten
    Dokumenttyp Buch
    HBZ-ID HT014764870
    ISBN 1-57340-224-9 ; 978-1-57340-224-8
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Zusatzmaterialien

    Kategorien

  6. Buch: Metabolic syndrome

    Grundy, Scott M.

    (Endocrinology and metabolism clinics of North America ; ...)

    2004  

    Verfasserangabe guest ed. Scott M. Grundy
    Serientitel Endocrinology and metabolism clinics of North America
    ...
    Sprache Englisch
    Erscheinungsverlauf 2004-9999
    Verlag Saunders
    Erscheinungsort Philadelphia u.a.
    Erscheinungsland Vereinigte Staaten
    Dokumenttyp Buch
    HBZ-ID HT014066514
    Datenquelle ZB MED Katalog Medizin, Gesundheit, Ernährung, Umwelt, Agrar

    Kategorien

  7. Buch: Metabolic syndrome / 2

    Grundy, Scott M.

    (Endocrinology and metabolism clinics of North America ; 33,3)

    2004  

    Verfasserangabe guest ed. Scott M. Grundy
    Serientitel Endocrinology and metabolism clinics of North America ; 33,3
    Metabolic syndrome
    Überordnung Metabolic syndrome
    Sprache Englisch
    Umfang XIII S., S. 467 - 626 : Ill., graph. Darst.
    Verlag Saunders
    Erscheinungsort Philadelphia u.a.
    Erscheinungsland Vereinigte Staaten
    Dokumenttyp Buch
    HBZ-ID HT014110502
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Zusatzmaterialien

    Kategorien

  8. Buch: Metabolic syndrome / 1

    Grundy, Scott M.

    (Endocrinology and metabolism clinics of North America ; 33,2)

    2004  

    Verfasserangabe guest ed. Scott M. Grundy
    Serientitel Endocrinology and metabolism clinics of North America ; 33,2
    Metabolic syndrome
    Überordnung Metabolic syndrome
    Sprache Englisch
    Umfang XI S., S. 267 - 465 : Ill., graph. Darst.
    Verlag Saunders
    Erscheinungsort Philadelphia u.a.
    Erscheinungsland Vereinigte Staaten
    Dokumenttyp Buch
    HBZ-ID HT014066544
    Datenquelle Katalog ZB MED Medizin, Gesundheit

    Zusatzmaterialien

    Kategorien

  9. Artikel: Statin therapy for primary prevention in women: What is the role for coronary artery calcium?

    Grundy, Scott M / Vega, Gloria Lena

    Journal of clinical lipidology

    2022  Band 16, Heft 4, Seite(n) 376–382

    Abstract: By current guidelines, statin treatment decisions depend on multiple risk factor algorithms (e.g., pooled cohort equations [PCEs]). By available PCEs most older middle-aged women are statin eligible. But several studies cast doubt on reliability of ... ...

    Abstract By current guidelines, statin treatment decisions depend on multiple risk factor algorithms (e.g., pooled cohort equations [PCEs]). By available PCEs most older middle-aged women are statin eligible. But several studies cast doubt on reliability of available PCEs for ASCVD risk assessment. An alternative method for risk assessment is a coronary artery calcium (CAC) score. Many older women have zero CAC, which equates to low risk for ASCVD; these women can delay statin therapy for several years before re-scanning. When CAC is 1-99 Agatston units, risk is only borderline high and statin delay also is an option until re-scanning. When CAC is > 100 Agatston units, risk is high enough to warrant a statin. In most women, CAC is the best guide to treatment decisions. In high-risk women (e.g., diabetes and severe hypercholesterolemia), generally are indicated, but CAC can assist in risk assessment, but other risk factors also can aid in treatment decisions.
    Mesh-Begriff(e) Aged ; Calcium ; Coronary Artery Disease/drug therapy ; Coronary Artery Disease/prevention & control ; Coronary Vessels/diagnostic imaging ; Female ; Humans ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Middle Aged ; Primary Prevention/methods ; Reproducibility of Results ; Risk Assessment ; Risk Factors ; Vascular Calcification/prevention & control
    Chemische Substanzen Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Calcium (SY7Q814VUP)
    Sprache Englisch
    Erscheinungsdatum 2022-05-08
    Erscheinungsland United States
    Dokumenttyp Editorial
    ZDB-ID 2365061-8
    ISSN 1876-4789 ; 1933-2874
    ISSN (online) 1876-4789
    ISSN 1933-2874
    DOI 10.1016/j.jacl.2022.05.001
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  10. Artikel ; Online: Is There a Role for Coronary Calcium in Patients With Diabetes?

    Grundy, Scott M / Vega, Gloria L / Wong, Nathan D

    The American journal of cardiology

    2023  Band 190, Seite(n) 98–101

    Abstract: In the primary prevention of atherosclerotic cardiovascular disease (ASCVD), a significant portion of high-risk patients have diabetes. Two decades ago, patients with or without cardiovascular disease were identified as having coronary heart disease (CHD) ...

    Abstract In the primary prevention of atherosclerotic cardiovascular disease (ASCVD), a significant portion of high-risk patients have diabetes. Two decades ago, patients with or without cardiovascular disease were identified as having coronary heart disease (CHD) risk equivalents because prospective studies showed that they were at risk for future CHD events equivalent to that of patients with established CHD. Thus, for patients with CHD, cholesterol guidelines recommended that patients with diabetes should be treated routinely with statins. However, recently, the treatment of diabetes has been greatly improved, and the risk for ASCVD has decreased. For this reason, it may be appropriate to re-evaluate the recommendations for routine use of statins in patients with diabetes. One of the major advances in the risk assessment for ASCVD is the introduction of coronary artery calcium measurement. This report will examine the role of coronary artery calcium scanning for the decision to initiate statin therapy in the primary prevention for patients with diabetes.
    Mesh-Begriff(e) Humans ; Cardiovascular Diseases/prevention & control ; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use ; Calcium ; Prospective Studies ; Diabetes Mellitus/epidemiology ; Risk Assessment ; Atherosclerosis ; Coronary Artery Disease/prevention & control ; Risk Factors
    Chemische Substanzen Hydroxymethylglutaryl-CoA Reductase Inhibitors ; Calcium (SY7Q814VUP)
    Sprache Englisch
    Erscheinungsdatum 2023-01-04
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Review
    ZDB-ID 80014-4
    ISSN 1879-1913 ; 0002-9149
    ISSN (online) 1879-1913
    ISSN 0002-9149
    DOI 10.1016/j.amjcard.2022.12.003
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang